Favipiravir drug shows promise against Chandipura virus in preclinical studies by NIV
Recent research has demonstrated the feasibility of using Favipiravir as a therapeutic option when it comes to Chandipura virus (CHPV). These preclinical studies were performed by the National Institute of Virology (NIV) in Pune, and showed that it was capable of decreasing the viral load in tissues and improving survival time in treated animals. Chandipura […]
Favipiravir drug shows promise against Chandipura virus in preclinical studies by NIV Read More »










